29/08/2023
Did you know that approximately 30% of the Australian population experiences IBS symptoms, with women three times more likely to experience IBS than men?
If you suffer from IBS, you can take part in our clinical trial using cannabidiol for potential treatment.
Visit our website for eligibility criteria and for more information: svgpharma.com.au
Schneider Von Gunn Pharmaceuticals has received Human Research Ethics Committee approval to commence the Genesis Trial. The Genesis Trial is a 4 week double-blind randomised placebo-controlled clinical trial to investigate the efficacy of CBD oil for the management of abdominal pain in patience suff...
